Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Deciphering the Impact of Common Genetic Variation on Lung Cancer Risk: A Genome-Wide Association Study
Cancer Research, 08/17/09
Broderick P et al. – The data indicate few common variants account for 1% of the excess familial risk underscoring the necessity of having additional large sample series for gene discovery.
Related Articles
Catching Lung Cancer Early
Ivanhoe, 12/09/09
Relevance Score: 71%%
Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Cancer Causes and Control, 12/03/09
Relevance Score: 71%%
Nutrition Aspects of Lung Cancer
Nutrition in Clinical Practice, 12/03/09
Relevance Score: 71%%
Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
British Journal of Cancer, 11/30/09
Relevance Score: 70%%
Pathophysiologic Correlation Between 62Cu-ATSM and 18F-FDG in Lung Cancer
The Journal of Nuclear Medicine, 11/17/09
Relevance Score: 70%%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma
Clinical Cancer Research, 12/11/09
Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma
Clinical Cancer Research, 12/11/09
Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation
British Journal of Haematology, 12/11/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer
Investigational New Drugs, 12/11/09
Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy
Cancer Chemotherapy and Pharmacology, 12/11/09
Stage I nonsmall cell lung cancer in patients aged >=75 years
Cancer, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


